EUVIMEDEUVIMED entdecken
Crossref

Dual-phase [18F]FDG PET/CT imaging in cervical carcinoma: enhanced metabolic characterization and novel prognostic indicators — a prospective study with paradigm-shifting clinical implications

Madan Gopal Vishnoi, Anurag Jain, Rajeev Akhariya, Vikrant Balaan, Kartikey P Solanki, Asima Bushra

Nuclear Medicine Review · 20.04.2026 · 29

DOI: 10.5603/nmr.111025 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nuclear Medicine Review, online erschienen am 20.04.2026. Verfasst von Madan Gopal Vishnoi und 5 weiteren Autor:innen. Beteiligte Einrichtung: Army Hospital Research and Referral, New Delhi, India. Hauptthemen laut MEDLINE: Uterine Cervical Neoplasms, Fluorodeoxyglucose F18, Positron Emission Tomography Computed Tomography.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Uterine Cervical NeoplasmsFluorodeoxyglucose F18Positron Emission Tomography Computed TomographyHumansFemalePrognosisProspective StudiesMiddle AgedAgedAdult

Stichwörter der Autor:innen

SUV kineticscervical cancerdual-phase [18F]FDG PET/CTextra-pelvic metastasismetabolic imagingprecision oncologyprognostic modeling

Substanzen

Fluorodeoxyglucose F18

Autor:innen und Institutionen

  • Army Hospital Research and Referral, New Delhi, India.
  • Armed Forces Medical Services, Lucknow, India. triplea.jain@gmail.com.
  • Armed Forces Medical Services, Lucknow, India.

Zitieren

APA

Vishnoi, M. G., Jain, A., Akhariya, R., Balaan, V., Solanki, K. P., & Bushra, A. (2026). Dual-phase [18F]FDG PET/CT imaging in cervical carcinoma: enhanced metabolic characterization and novel prognostic indicators — a prospective study with paradigm-shifting clinical implications. Nuclear Medicine Review, 29(0). https://doi.org/10.5603/nmr.111025

Vancouver

Vishnoi MG, Jain A, Akhariya R, Balaan V, Solanki KP, Bushra A. Dual-phase [18F]FDG PET/CT imaging in cervical carcinoma: enhanced metabolic characterization and novel prognostic indicators — a prospective study with paradigm-shifting clinical implications. Nuclear Medicine Review. 2026;29(0). doi:10.5603/nmr.111025

BibTeX
@article{Vishnoi2026,
  author = {Vishnoi, Madan Gopal and Jain, Anurag and Akhariya, Rajeev and Balaan, Vikrant and Solanki, Kartikey P and Bushra, Asima},
  title = {Dual-phase [18F]FDG PET/CT imaging in cervical carcinoma: enhanced metabolic characterization and novel prognostic indicators — a prospective study with paradigm-shifting clinical implications},
  journal = {Nuclear Medicine Review},
  year = {2026},
  volume = {29},
  number = {0},
  doi = {10.5603/nmr.111025}
}
Kostenlos starten →